H2OPTX

San Jose, United States Founded: 2012 • Age: 14 yrs
Imaging solutions for pharmaceutical chemical structure analysis are provided.

About H2OPTX

H2OPTX is a company based in San Jose (United States) founded in 2012. H2OPTX operates in a competitive market with competitors including Bruker, Asimov, Cellarity, Metrohm and Metaphore, among others.

Key Metrics
  • Latest Funding Round
    $65.29K (USD), Grant

    Sep 2017

  • Investors

Funding Insights of H2OPTX

  • Total Rounds 1
  • Last Round Grant β€” $65,290
  • First Round $65,290

    (Sep 2017)

  • Investors Count 1

All 1 funding rounds of H2OPTX with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Sep 2017$65,290Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in H2OPTX

H2OPTX has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov-
Premium access

Investor details for H2OPTX

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of H2OPTX

2 dated milestones of H2OPTX across 5 years, from founding to its latest funding, stage changes and deals.

  1. Founded H2OPTX is founded.
  2. Funding First funding round of $65K.

Competitors of H2OPTX

H2OPTX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bruker, Asimov, Cellarity, Metrohm and Metaphore, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
bruker.com1960United States–9,707
Diversified research instrument systems are manufactured and supplied.
asimov.com2017Boston, United States$209.4M87
Provider of integrated suite for advanced genetic design and manufacturing
cellarity.com2015Cambridge, United States$294M117
Developer of drugs to treat various diseases
metrohm.com1943Herisau, Switzerland–608
Instruments for chemical analysis are developed and manufactured.
metaphorebio.com2021Cambridge, United States$50M–
Provider of machine language and computational platform for drug discovery
impedimed.com1999Carlsbad, United States$3.44M76
Technologies for non-invasive fluid status assessment and monitoring are developed.
panakeia.ai2018London, United Kingdom$3.79M12
AI-based software is provided for cancer diagnosis and precision treatment.
evolvedbynature.com2013Medford, United States$190M99
Digital technology for biomedicinal molecule development in research is utilized.
algorithmicbiologics.com2021Bengaluru, India$2.84M–
Provider of software solutions for molecular diagnostics and discovery
speclipse.com2015Seongnam-si, South Korea$10.55M–
Molecular spectroscopy systems for early skin cancer detection are provided.
Premium access

Detailed competitors of H2OPTX

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Similar companies to H2OPTX

10 companies that operate in the same segment as H2OPTX (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B––
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about H2OPTX

H2OPTX was founded in 2012 and raised its 1st funding round 5 years after it was founded.

H2OPTX is headquartered in San Jose, United States. It is registered at San Jose, California, United States.

Founded in 2012 and based in San Jose, United States, H2OPTX operates in the pharmaceuticals sector. Solutions integrating Raman spectroscopy, optical, and UV microscopy are developed for analyzing chemical structures. Tablets and large volumes of complex powders are scanned using automated X-Y-Z surface methods. Software for processing multi-spectral data from the H2Optx mPAT LAB system is offered, along with RD and IP development services.

H2OPTX's top competitors include Asimov, Cellarity and Bruker.

H2OPTX has 1 investor. Key investors include HHS.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available